Varpu Jokimaa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Varpu Jokimaa has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Hannele Laivuori
Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
2 shared publications Harry Kujari
Institute of Biomedicine, Research Center for Cancer, Infections and Immunity, University of Turku, 20014, Turku, Finland
2 shared publications- Kristiina Aittomäki
Department of Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
2 shared publications - Laure Morin-Papunen
Research Unit of Clinical Medicine, Department of Obstetrics and Gynecology, Medical Research Center Oulu University Hospital, University of Oulu Oulu Finland
2 shared publications - Maria Sandbacka
Folkhälsan Institute of Genetics, Helsinki, Finland.
2 shared publications - Mervi Halttunen
Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland
2 shared publications
Latest Publications
- Open Access
- 18 October 2024
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 103 (12) , 2554-2565
Chronotypes in middle‐aged women with polycystic ovary syndrome: A population‐based study
Introduction: Circadian rhythm disruption has been associated with the risk of polycystic ovary syndrome (PCOS), as the evening chronotype (EC) shares several traits with PCOS, including metabolic disorders, cardiovascular diseases, and psychiatric disorders. It has been suggested that the biological clock could be targeted with new, preventive, and therapeutic strategies for PCOS in women with biorhythm disorders. We evaluated inner circadian rhythmicity in middle‐aged women with PCOS in a population‐based setting, focusing on whether women with PCOS and an EC have a specific subtype in relation to their clinical characteristics.Material and Methods: The data derived from the Northern Finland Birth Cohort, a population‐based longitudinal birth cohort of 12 058 individuals born in 1966. We compared the circadian phenotype between 314 women with PCOS (according to the Rotterdam criteria) and 1248 women without PCOS at age 46 years using the validated Finnish shortened 6‐item Morningness‐Eveningness Questionnaire (sMEQ) and the single‐item self‐assessed morningness‐eveningness question.Results: PCOS was not associated with the EC by the sMEQ (p = 0.495) or self‐assessment (p = 0.303). The self‐assessed morningness‐eveningness values differed from the sMEQ chronotype distribution (p < 0.001), nevertheless, the most frequent chronotype was the intermediate chronotype (IC) determined by both chronotyping methods (sMEQ PCOS 47.7% vs. 45.2% non‐PCOS; self‐assessment PCOS 66.5% vs. 68.4% non‐PCOS). The hyperandrogenic PCOS phenotypes A–C did not differ from the non‐hyperandrogenic phenotype D as for the chronotype (p = 0.271). The EC was associated in both groups with depressive and anxiety symptoms (PCOS p = 0.012, non‐PCOS p < 0.001) and the use of sleep medication (PCOS p = 0.017, non‐PCOS p < 0.001).Conclusions: The EC was not over‐represented in middle‐aged women with PCOS or in the hyperandrogenic PCOS phenotypes A–C in our study. This does not support the need for chronotyping in the comprehensive assessment of women with PCOS. However, as chronotypes tend to change with aging, cross‐sectional studies in different age groups are warranted to draw conclusions on the role of chronotypes in PCOS and the associated metabolic risks.
- 18 October 2024
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 103 (12) , 2554-2565
Open AccessChronotypes in middle‐aged women with polycystic ovary syndrome: A population‐based study
Introduction: Circadian rhythm disruption has been associated with the risk of polycystic ovary syndrome (PCOS), as the evening chronotype (EC) shares several traits with PCOS, including metabolic disorders, cardiovascular diseases, and psychiatric disorders. It has been suggested that the biological clock could be targeted with new, preventive, and therapeutic strategies for PCOS in women with biorhythm disorders. We evaluated inner circadian rhythmicity in middle‐aged women with PCOS in a population‐based setting, focusing on whether women with PCOS and an EC have a specific subtype in relation to their clinical characteristics.Material and Methods: The data derived from the Northern Finland Birth Cohort, a population‐based longitudinal birth cohort of 12 058 individuals born in 1966. We compared the circadian phenotype between 314 women with PCOS (according to the Rotterdam criteria) and 1248 women without PCOS at age 46 years using the validated Finnish shortened 6‐item Morningness‐Eveningness Questionnaire (sMEQ) and the single‐item self‐assessed morningness‐eveningness question.Results: PCOS was not associated with the EC by the sMEQ (p = 0.495) or self‐assessment (p = 0.303). The self‐assessed morningness‐eveningness values differed from the sMEQ chronotype distribution (p < 0.001), nevertheless, the most frequent chronotype was the intermediate chronotype (IC) determined by both chronotyping methods (sMEQ PCOS 47.7% vs. 45.2% non‐PCOS; self‐assessment PCOS 66.5% vs. 68.4% non‐PCOS). The hyperandrogenic PCOS phenotypes A–C did not differ from the non‐hyperandrogenic phenotype D as for the chronotype (p = 0.271). The EC was associated in both groups with depressive and anxiety symptoms (PCOS p = 0.012, non‐PCOS p < 0.001) and the use of sleep medication (PCOS p = 0.017, non‐PCOS p < 0.001).Conclusions: The EC was not over‐represented in middle‐aged women with PCOS or in the hyperandrogenic PCOS phenotypes A–C in our study. This does not support the need for chronotyping in the comprehensive assessment of women with PCOS. However, as chronotypes tend to change with aging, cross‐sectional studies in different age groups are warranted to draw conclusions on the role of chronotypes in PCOS and the associated metabolic risks.
- Open Access
- 28 July 2020
- Published by Springer Nature in BMC Women's Health
- Vol. 20 (1) , 1-6
A Mayer-Rokitansky-Kuster-Hauser patient with leiomyoma and dysplasia of neovagina: a case report
Background: Most patients with congenital uterus and vaginal aplasia (i.e., Mayer–Rokitansky–Kuster–Hauser [MRKH] syndrome) have rudimentary pelvic uterine structures that contain smooth muscle. Although leiomyomas and dysplasia of vaginal mucosa are relatively common in the general population, they are rare in MRKH patients. Data on the vulnerability of neovaginas to HPV-associated dysplasia are limited. Case presentation: A rare case of an MRKH patient with two gynaecological conditions detected during long-term gynaecological follow-up is presented. At the age of 21, the patient was treated for HPV-associated neovaginal dysplasia. At the age of 47, a pelvic leiomyoma was detected with transvaginal ultrasound and confirmed with magnetic resonance imaging. Conclusion: A Pap smear or human papillomavirus testing is indicated in sexually active MRKH women. Uterine rudiments contain smooth muscle, which facilitates the development of oestrogen-dependent diseases, such as leiomyomas and adenomyosis. Although magnetic resonance imaging is recommended in cases of a pelvic mass, easily attainable and cost-efficient transvaginal ultrasound offers high diagnostic accuracy in patients with a surgically created neovagina and is suitable for the patients’ follow-up. Guidelines for the gynaecological follow-up of MRKH patients are warranted.
- 28 July 2020
- Published by Springer Nature in BMC Women's Health
- Vol. 20 (1) , 1-6
Open AccessA Mayer-Rokitansky-Kuster-Hauser patient with leiomyoma and dysplasia of neovagina: a case report
Background: Most patients with congenital uterus and vaginal aplasia (i.e., Mayer–Rokitansky–Kuster–Hauser [MRKH] syndrome) have rudimentary pelvic uterine structures that contain smooth muscle. Although leiomyomas and dysplasia of vaginal mucosa are relatively common in the general population, they are rare in MRKH patients. Data on the vulnerability of neovaginas to HPV-associated dysplasia are limited. Case presentation: A rare case of an MRKH patient with two gynaecological conditions detected during long-term gynaecological follow-up is presented. At the age of 21, the patient was treated for HPV-associated neovaginal dysplasia. At the age of 47, a pelvic leiomyoma was detected with transvaginal ultrasound and confirmed with magnetic resonance imaging. Conclusion: A Pap smear or human papillomavirus testing is indicated in sexually active MRKH women. Uterine rudiments contain smooth muscle, which facilitates the development of oestrogen-dependent diseases, such as leiomyomas and adenomyosis. Although magnetic resonance imaging is recommended in cases of a pelvic mass, easily attainable and cost-efficient transvaginal ultrasound offers high diagnostic accuracy in patients with a surgically created neovagina and is suitable for the patients’ follow-up. Guidelines for the gynaecological follow-up of MRKH patients are warranted.
- 10 September 2018
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 98 (1) , 44-50
Vaginal cuff dehiscence is observed in a higher rate after total laparoscopic hysterectomy compared with other types of hysterectomy
Introduction: Recently, it has been suggested that the occurrence of posthysterectomy vaginal cuff dehiscence has increased. Consequently, we evaluated the incidence of vaginal cuff dehiscence after different types of hysterectomies. Our hypothesis is that vaginal cuff dehiscence is more often associated with total laparoscopic hysterectomy (TLH) than other types of uterine removal.Material and methods: A total of 13 645 hysterectomies from 1992 to 2015 were evaluated in the Turku University Hospital district, Finland. The primary outcome was occurrence of vaginal dehiscence after different types of hysterectomy. The hysterectomy and postoperative vaginal dehiscence trends were analyzed as the secondary outcome. In a subanalysis of dehiscence cases, women’s characteristics and perioperative vaginal cuff opening and closure techniques were compared between conventional hysterectomies (vaginal, abdominal, and laparoscopic with vaginal closure) and TLH.Results: Altogether, 22 cases of vaginal cuff dehiscence were included. Most cases (n = 15) occurred after TLH (n = 1104), resulting in an incidence of 1.27%. After conventional laparoscopic hysterectomy with vaginal closure (n = 2853), vaginal (n = 4150), and abdominal (n = 5538) hysterectomies, the incidence rates were 0.11%, 0.05%, and 0.02%, respectively. Compared to abdominal hysterectomy, which was associated with the lowest incidence rate, vaginal dehiscence after TLH had an odds ratio (OR) 71.1 (9.34‐541.38, P < 0.001). In the subanalysis of possible underlying factors, the technique of opening of the vaginal cuff with or without electrocoagulation, duration of operation, and occurrence of postoperative infection or hematoma prior to VCD were observed differences between TLH and conventional hysterectomies.Conclusions: Compared with other types of hysterectomies, vaginal dehiscence was observed at the highest rate after TLH. Studies are needed to define if vaginal opening technique contributes to the risk of dehiscence.
- 10 September 2018
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 98 (1) , 44-50
Vaginal cuff dehiscence is observed in a higher rate after total laparoscopic hysterectomy compared with other types of hysterectomy
Introduction: Recently, it has been suggested that the occurrence of posthysterectomy vaginal cuff dehiscence has increased. Consequently, we evaluated the incidence of vaginal cuff dehiscence after different types of hysterectomies. Our hypothesis is that vaginal cuff dehiscence is more often associated with total laparoscopic hysterectomy (TLH) than other types of uterine removal.Material and methods: A total of 13 645 hysterectomies from 1992 to 2015 were evaluated in the Turku University Hospital district, Finland. The primary outcome was occurrence of vaginal dehiscence after different types of hysterectomy. The hysterectomy and postoperative vaginal dehiscence trends were analyzed as the secondary outcome. In a subanalysis of dehiscence cases, women’s characteristics and perioperative vaginal cuff opening and closure techniques were compared between conventional hysterectomies (vaginal, abdominal, and laparoscopic with vaginal closure) and TLH.Results: Altogether, 22 cases of vaginal cuff dehiscence were included. Most cases (n = 15) occurred after TLH (n = 1104), resulting in an incidence of 1.27%. After conventional laparoscopic hysterectomy with vaginal closure (n = 2853), vaginal (n = 4150), and abdominal (n = 5538) hysterectomies, the incidence rates were 0.11%, 0.05%, and 0.02%, respectively. Compared to abdominal hysterectomy, which was associated with the lowest incidence rate, vaginal dehiscence after TLH had an odds ratio (OR) 71.1 (9.34‐541.38, P < 0.001). In the subanalysis of possible underlying factors, the technique of opening of the vaginal cuff with or without electrocoagulation, duration of operation, and occurrence of postoperative infection or hematoma prior to VCD were observed differences between TLH and conventional hysterectomies.Conclusions: Compared with other types of hysterectomies, vaginal dehiscence was observed at the highest rate after TLH. Studies are needed to define if vaginal opening technique contributes to the risk of dehiscence.
- Open Access
- 9 February 2015
- Published by Wiley in Clinical Case Reports
- Vol. 3 (4) , 260-265
A case of conjoined twins after a transfer of a multinuclear embryo
Key Clinical Message A pregnancy with conjoined twins was observed after transfer of a multinuclear embryo. As nuclear mechanisms have a role in cellular differentiation, association between multinucleation and fetal malformations is possible. Follow‐up studies on children born after transfer of embryos with bi/multinuclear blastomeres are needed.
- 9 February 2015
- Published by Wiley in Clinical Case Reports
- Vol. 3 (4) , 260-265
Open AccessA case of conjoined twins after a transfer of a multinuclear embryo
Key Clinical Message A pregnancy with conjoined twins was observed after transfer of a multinuclear embryo. As nuclear mechanisms have a role in cellular differentiation, association between multinucleation and fetal malformations is possible. Follow‐up studies on children born after transfer of embryos with bi/multinuclear blastomeres are needed.
- Open Access
- 16 August 2013
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 8 (1) , 125
TBX6, LHX1 and copy number variations in the complex genetics of Müllerian aplasia
Background: Müllerian aplasia (MA) is a congenital disorder of the female reproductive tract with absence of uterus and vagina with paramount impact on a woman’s life. Despite intense research, no major genes have been found to explain the complex genetic etiology.Methods and Results: We have used several genetic methods to study 112 patients with MA. aCGH identified CNVs in 8/50 patients (16%), including 16p11.2 and 17q12 deletions previously associated with MA. Subsequently, another four patients were shown to carry the ~0.53 Mb deletion in 16p11.2. More importantly, sequencing ofTBX6,residing within 16p11.2, revealed two patients carrying a splice site mutation.Two previously reportedTBX6variants in exon 4 and 6 were shown to have a significantly higher frequency in patients (8% and 5%, respectively) than in controls (2% each). We also sequencedLHX1and found three apparently pathogenic missense variants in 5/112 patients. Altogether, we identified either CNVs or variations inTBX6orLHX1in 30/112 (26.8%) MA patients. CNVs were found in 12/112 (10.7%), patients, novel variants inTBX6orLHX1in 7/112 (6.3%), and rare variants inTBX6in 15/112 (13.4%) patients. Furthermore, four of our patients (4/112, 3.6%) were shown to carry variants in bothTBX6andLHX1or a CNV in combination withTBX6variants lending support to the complex genetic etiology of MA.Conclusions: We have identifiedTBX6as a new gene associated with MA. Our results also support the relevance ofLHX1and CNVs in the development of this congenital malformation.
- 16 August 2013
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 8 (1) , 125
Open AccessTBX6, LHX1 and copy number variations in the complex genetics of Müllerian aplasia
Background: Müllerian aplasia (MA) is a congenital disorder of the female reproductive tract with absence of uterus and vagina with paramount impact on a woman’s life. Despite intense research, no major genes have been found to explain the complex genetic etiology.Methods and Results: We have used several genetic methods to study 112 patients with MA. aCGH identified CNVs in 8/50 patients (16%), including 16p11.2 and 17q12 deletions previously associated with MA. Subsequently, another four patients were shown to carry the ~0.53 Mb deletion in 16p11.2. More importantly, sequencing ofTBX6,residing within 16p11.2, revealed two patients carrying a splice site mutation.Two previously reportedTBX6variants in exon 4 and 6 were shown to have a significantly higher frequency in patients (8% and 5%, respectively) than in controls (2% each). We also sequencedLHX1and found three apparently pathogenic missense variants in 5/112 patients. Altogether, we identified either CNVs or variations inTBX6orLHX1in 30/112 (26.8%) MA patients. CNVs were found in 12/112 (10.7%), patients, novel variants inTBX6orLHX1in 7/112 (6.3%), and rare variants inTBX6in 15/112 (13.4%) patients. Furthermore, four of our patients (4/112, 3.6%) were shown to carry variants in bothTBX6andLHX1or a CNV in combination withTBX6variants lending support to the complex genetic etiology of MA.Conclusions: We have identifiedTBX6as a new gene associated with MA. Our results also support the relevance ofLHX1and CNVs in the development of this congenital malformation.
- Open Access
- 1 January 2011
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 6 (1) , 53
Evaluation of SHOX copy number variations in patients with Müllerian aplasia
Müllerian aplasia (MA) characterized by congenital loss of functional uterus and vagina is one of the most difficult disorders of female reproductive health. Despite of growing interest in this research field, the cause of the disorder for the majority of patients is still unknown. A recent report of partial SHOX duplications in five patients with MA has motivated us to further evaluate their role in the disorder. Therefore we have studied SHOX copy number variations (CNVs) in a cohort of 101 Finnish patients with MA and in 115 healthy controls.
- 1 January 2011
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 6 (1) , 53
Open AccessEvaluation of SHOX copy number variations in patients with Müllerian aplasia
Müllerian aplasia (MA) characterized by congenital loss of functional uterus and vagina is one of the most difficult disorders of female reproductive health. Despite of growing interest in this research field, the cause of the disorder for the majority of patients is still unknown. A recent report of partial SHOX duplications in five patients with MA has motivated us to further evaluate their role in the disorder. Therefore we have studied SHOX copy number variations (CNVs) in a cohort of 101 Finnish patients with MA and in 115 healthy controls.
- 1 January 2006
- Vol. 122 (4) , 434-40
[Immediate complications of in vitro fertilization].
- Open Access
- 1 December 2002
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 8 (12) , 1111-1116
Altered expression of genes involved in the production and degradation of endometrial extracellular matrix in patients with unexplained infertility and recurrent miscarriages
During the secretory phase of the menstrual cycle, the composition of extracellular matrix (ECM) in endometrium changes to favour implantation. In the present study, we have analysed whether some cases of unexplained infertility and recurrent abortions could be explained by abnormal production or turnover of endometrial ECM. Comparison of mRNA levels of a panel of collagens, matrix metalloproteinases (MMP), tissue inhibitors of metalloproteinases (TIMP) and cathepsins in the samples revealed higher levels of type I collagen, MMP-2 and cathepsin H and decreased levels of TIMP-3 mRNA in mid-secretory endometrium of patients with unexplained infertility and/or recurrent miscarriages when compared with normal mid-secretory endometrium. Furthermore, changes were also seen in the levels of type I collagen and TIMP-3 mRNA between the proliferative and mid-secretory phases of normal endometrium. The results suggest an altered ECM turnover in the endometrium of patients with fertility disorders prior to implantation.
- 1 December 2002
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 8 (12) , 1111-1116
Open AccessAltered expression of genes involved in the production and degradation of endometrial extracellular matrix in patients with unexplained infertility and recurrent miscarriages
During the secretory phase of the menstrual cycle, the composition of extracellular matrix (ECM) in endometrium changes to favour implantation. In the present study, we have analysed whether some cases of unexplained infertility and recurrent abortions could be explained by abnormal production or turnover of endometrial ECM. Comparison of mRNA levels of a panel of collagens, matrix metalloproteinases (MMP), tissue inhibitors of metalloproteinases (TIMP) and cathepsins in the samples revealed higher levels of type I collagen, MMP-2 and cathepsin H and decreased levels of TIMP-3 mRNA in mid-secretory endometrium of patients with unexplained infertility and/or recurrent miscarriages when compared with normal mid-secretory endometrium. Furthermore, changes were also seen in the levels of type I collagen and TIMP-3 mRNA between the proliferative and mid-secretory phases of normal endometrium. The results suggest an altered ECM turnover in the endometrium of patients with fertility disorders prior to implantation.